Publications

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 31, 2022

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions

January 19, 2022

Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP) best practices and recommendations for FAIR data, toward alignment with International Regulatory agencies

November 16, 2022

The culture of research communication in neonatal intensive care units: key stakeholder perspectives

November 16, 2021

Parent Editorial: The culture of research communication in neonatal intensive care units: key stakeholder perspectives

October 5, 2021

Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19

September 29, 2021

Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review

C-Path's Huntington's Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based...

September 14, 2021

Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data

August 7, 2021

Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review

August 1, 2021

A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation

Ahamadi M, Mehrotra N, Hanan N, Lai Yee K, Gheyas F, Anton J, Bani M, Boroojerdi B, Smit H, Weidemann J, Macha S, Thuillier V...

July 8, 2021

Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective

Stephenson D, Badawy R, Mathur S, Tome M, Rochester L. Digital Progression Biomarkers as Novel Endpoints in Clinical Trials...

Previous78 9...32 Next